1.Ameliorative Effect of Bone Marrow-Derived Stem Cells on Injured Liver of Mice Infected with Schistosoma mansoni.
Magda M EL-MAHDI ; Wafaa A MANSOUR ; Olfat HAMMAM ; Noha A MEHANA ; Taghreed M HUSSEIN
The Korean Journal of Parasitology 2014;52(2):151-162
The technique of stem cells or hepatocytes transplantation has recently improved in order to bridge the time before whole-organ liver transplantation. In the present study, unfractionated bone marrow stem cells (BMSCs) were harvested from the tibial and femoral marrow compartments of male mice, which were cultured in Dulbecco's modified Eagle's medium (DMEM) with and without hepatocyte growth factor (HGF), and then transplanted into Schistosoma mansoni-infected female mice on their 8th week post-infection. Mice were sacrificed monthly until the third month of bone marrow transplantation, serum was collected, and albumin concentration, ALT, AST, and alkaline phosphatase (ALP) activities were assayed. On the other hand, immunohistopathological and immunohistochemical changes of granuloma size and number, collagen content, and cells expressing OV-6 were detected for identification of liver fibrosis. BMSCs were shown to differentiate into hepatocyte-like cells. Serum ALT, AST, and ALP were markedly reduced in the group of mice treated with BMSCs than in the untreated control group. Also, granuloma showed a marked decrease in size and number as compared to the BMSCs untreated group. Collagen content showed marked decrease after the third month of treatment with BMSCs. On the other hand, the expression of OV-6 increased detecting the presence of newly formed hepatocytes after BMSCs treatment. BMSCs with or without HGF infusion significantly enhanced hepatic regeneration in S. mansoni-induced fibrotic liver model and have pathologic and immunohistopathologic therapeutic effects. Also, this new therapeutic trend could generate new hepatocytes to improve the overall liver functions.
Alanine Transaminase/blood
;
Alkaline Phosphatase/blood
;
Animals
;
Antigens, Differentiation/biosynthesis
;
Aspartate Aminotransferases/blood
;
Bone Marrow Cells/cytology
;
*Bone Marrow Transplantation
;
Cell Differentiation
;
Cell- and Tissue-Based Therapy
;
Cells, Cultured
;
Collagen/metabolism
;
Female
;
Granuloma/parasitology/pathology
;
Hepatocyte Growth Factor/pharmacology
;
Hepatocytes/*cytology
;
Liver/parasitology/pathology
;
Liver Cirrhosis/parasitology/pathology/*therapy
;
Male
;
Mice
;
Mice, Inbred BALB C
;
Schistosoma mansoni/pathogenicity
;
Schistosomiasis mansoni/mortality/*therapy
;
*Stem Cell Transplantation
;
Stem Cells/cytology
2.Effect of Ketoconazole, a Cytochrome P450 Inhibitor, on the Efficacy of Quinine and Halofantrine against Schistosoma mansoni in Mice.
Sayed Hassan SEIF EL-DIN ; Abdel Nasser Abdel Aal SABRA ; Olfat Ali HAMMAM ; Naglaa Mohamed EL-LAKKANY
The Korean Journal of Parasitology 2013;51(2):165-175
The fear that schistosomes will become resistant to praziquantel (PZQ) motivates the search for alternatives to treat schistosomiasis. The antimalarials quinine (QN) and halofantrine (HF) possess moderate antischistosomal properties. The major metabolic pathway of QN and HF is through cytochrome P450 (CYP) 3A4. Accordingly, this study investigates the effects of CYP3A4 inhibitor, ketoconazole (KTZ), on the antischistosomal potential of these quinolines against Schistosoma mansoni infection by evaluating parasitological, histopathological, and biochemical parameters. Mice were classified into 7 groups: uninfected untreated (I), infected untreated (II), infected treated orally with PZQ (1,000 mg/kg) (III), QN (400 mg/kg) (IV), KTZ (10 mg/kg)+QN as group IV (V), HF (400 mg/kg) (VI), and KTZ (as group V)+HF (as group VI) (VII). KTZ plus QN or HF produced more inhibition (P<0.05) in hepatic CYP450 (85.7% and 83.8%) and CYT b5 (75.5% and 73.5%) activities, respectively, than in groups treated with QN or HF alone. This was accompanied with more reduction in female (89.0% and 79.3%), total worms (81.4% and 70.3%), and eggs burden (hepatic; 83.8%, 66.0% and intestinal; 68%, 64.5%), respectively, and encountering the granulomatous reaction to parasite eggs trapped in the liver. QN and HF significantly (P<0.05) elevated malondialdehyde levels when used alone or with KTZ. Meanwhile, KTZ plus QN or HF restored serum levels of ALT, albumin, and reduced hepatic glutathione (KTZ+HF) to their control values. KTZ enhanced the therapeutic antischistosomal potential of QN and HF over each drug alone. Moreover, the effect of KTZ+QN was more evident than KTZ+HF.
Animals
;
Anthelmintics/*administration & dosage
;
Disease Models, Animal
;
Drug Synergism
;
Female
;
Humans
;
Intestines/parasitology
;
Ketoconazole/*administration & dosage
;
Liver/parasitology/pathology
;
Male
;
Mice
;
Parasite Load
;
Phenanthrenes/*administration & dosage
;
Quinine/*administration & dosage
;
Schistosoma mansoni/isolation & purification
;
Schistosomiasis mansoni/*drug therapy/pathology
;
Treatment Outcome